Republic Healthcare Limited (HK:8357)

:8357

8357

Republic Healthcare Limited

RESEARCH TOOLSreports

Republic Healthcare Limited (8357) Price & Analysis

0 Followers

8357 Stock Chart & Stats

HK$0.12

HK$0.00(0.00%)

At close: Jan 03 4:00 PM EST

HK$0.12

HK$0.00(0.00%)

Day’s Range― - ―

52-Week RangeHK$0.06 - HK$0.24

Previous CloseN/A

Volume50.00K

Average Volume (3M)282.67K

Market Cap

HK$87.98M

Enterprise ValueHK$12.94M

Total Cash (Recent Filing)HK$9.75M

Total Debt (Recent Filing)HK$1.25M

Price to Earnings (P/E)―

Beta0.17

Next Earnings

Jul 31, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding624,000,000

10 Day Avg. Volume457,500

30 Day Avg. Volume282,666

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)1.51

Price to Sales (P/S)1.84

P/FCF Ratio-4.63

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet HistoryA multi-year track record of low leverage (2021–2024) indicates the company historically preserved financial flexibility. That conservatism can help absorb cyclical shocks, support funding access, and provide runway for operational adjustments when performance weakens.

Sizable Equity BufferA sizable equity base relative to assets provides a meaningful capital cushion against losses and supports solvency over the medium term. This structural cushion reduces immediate liquidation risk and improves capacity to raise debt or equity if turnaround actions are needed.

Proven Cash Generation In Better YearsPrior positive operating and free cash flow in 2023–2024 shows the business model can generate cash under normal conditions. That historical cash-generation ability implies operational levers exist to restore free cash flow if revenue and margins stabilize, supporting medium-term recovery prospects.

Bears Say

Worsening ProfitabilityA gross loss and materially larger operating/net losses signal deteriorating unit economics and margin erosion. Persistent multi-year revenue declines (~10% then ~8%) reduce scale benefits, squeeze margins, and undermine reinvestment capacity, making earnings recovery harder without structural change.

Negative Operating And Free Cash FlowTurning to negative operating and free cash flow in 2025—after prior positive years—and historical cash volatility indicates weak cash conversion. Sustained negative cash flow pressures liquidity, forces reliance on external financing, and limits ability to fund capex or strategic initiatives organically.

Step-up In Debt Amid LossesA sharp increase in debt while profitability deteriorates raises leverage and refinancing risk. Higher interest and principal obligations reduce financial flexibility, increase default probability if losses persist, and can lead to dilution or covenant constraints that hamper recovery efforts.

8357 FAQ

What was Republic Healthcare Limited’s price range in the past 12 months?

Republic Healthcare Limited lowest stock price was HK$0.06 and its highest was HK$0.24 in the past 12 months.

What is Republic Healthcare Limited’s market cap?

Republic Healthcare Limited’s market cap is HK$87.98M.

When is Republic Healthcare Limited’s upcoming earnings report date?

Republic Healthcare Limited’s upcoming earnings report date is Jul 31, 2026 which is in 111 days.

How were Republic Healthcare Limited’s earnings last quarter?

Republic Healthcare Limited released its earnings results on Mar 26, 2026. The company reported -HK$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.017.

Is Republic Healthcare Limited overvalued?

According to Wall Street analysts Republic Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Republic Healthcare Limited pay dividends?

Republic Healthcare Limited does not currently pay dividends.

What is Republic Healthcare Limited’s EPS estimate?

Republic Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Republic Healthcare Limited have?

Republic Healthcare Limited has 624,000,000 shares outstanding.

What happened to Republic Healthcare Limited’s price movement after its last earnings report?

Republic Healthcare Limited reported an EPS of -HK$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.759%.

Which hedge fund is a major shareholder of Republic Healthcare Limited?

Currently, no hedge funds are holding shares in HK:8357

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Republic Healthcare Limited Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-27.01%

Trailing 12-Months

Asset Growth

18.49%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Republic Healthcare Limited

Republic Healthcare Limited, a primary healthcare services company, provides consultation, medical investigation, and treatment services in Singapore. The company offers various treatment solutions for common medical conditions and focuses on sexual health and infectious diseases. It also provides treatment solutions for common skin conditions and basic medical aesthetics services. The company operates nine clinics under the Dr. Tan & Partners brand name; and one clinic under the S Aesthetics brand name. Republic Healthcare Limited was founded in 2010 and is headquartered in Singapore.